This task order is for (a) downstream engineering run production, (b) downstream current good manufacturing practices manufacturing production (cgmp), (c) fill/finish & labeling, (d) analytical…
Active Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,721,455
Award facts
- Contract value 94% obligated
-
- $6,721,455.00 Current, with exercised options
- $7,177,446.00 Potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $479,043 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,619,441 | |
| Funding Only Action | $0 | |
| Exercise an Option | $423,033 | |
| Original award | $4,199,938 |
About this award
This is a delivery order issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) on August 29, 2021. The $7,177,446.00 order is for downstream engineering run production, downstream current Good Manufacturing Practices (cGMP) manufacturing, fill/finish and labeling, analytical development/release, and accelerated stability testing. The work supports NIAID's preclinical development initiatives. ABL is a contract research and manufacturing organization focused on biologics development, including vaccines, monoclonal antibodies, and other infectious disease countermeasures. ABL has been awarded multiple federal contracts and grants by NIH and other agencies to provide a range of development and manufacturing services. This order is not designated as a set-aside.
Description
This task order is for (a) downstream engineering run production, (b) downstream current good manufacturing practices manufacturing production (cgmp), (c) fill/finish & labeling, (d) analytical development/release (e) accelerated stability testin
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 29, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $6,721,455 on 75N93021F00002. Its potential value, with all options, is $7,177,446.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award